Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
05/2012
05/18/2012CA2812669A1 Pyrazole aminopyrimidine derivatives as lrrk2 modulators
05/18/2012CA2812667A1 Triazole derivatives and their use for neurological disorders
05/17/2012US20120123120 No-Carrier-Added Nucleophilic [F-18] Fluorination of Aromatic Compounds
05/17/2012US20120123115 Cyclic guanidine ionic liquid
05/17/2012US20120123114 Quinazoline derivatives having tyrosine kinase inhibitory activity
05/17/2012US20120122931 Indole derivative or pharmaceutically acceptable salt thereof
05/17/2012US20120122905 Novel gpr 119 agonists
05/17/2012US20120122884 Compounds useful as inhibitors of atr kinase
05/17/2012US20120122869 Trizaole compounds that modulate hsp90 activity
05/17/2012US20120122868 Apaf-1 inhibitor compounds
05/17/2012US20120122867 Novel pyrimidine derivatives and their use in the treatment of cancer and further diseases
05/17/2012US20120122865 Isoindoline compounds and methods of their use
05/17/2012US20120122864 Inhibitors of hcv ns5a
05/17/2012US20120122863 Quinazolinedione Chymase Inhibitors
05/17/2012US20120122862 Arginine derivatives with np-i antagonistic activity
05/17/2012US20120122857 Heterobicyclic carboxamides as inhibitors for kinases
05/17/2012US20120122855 Benzoxazines, benzothiazines, and related compounds having nos inhibitory activity
05/17/2012US20120122854 Carbocyclic Fused Cyclic Amines
05/17/2012US20120122853 Annelated n-heterocyclic sulfonamides with oxadiazolone headgroup, processes for their preparation and their use as pharmaceuticals
05/17/2012US20120122850 Biphenyl compounds useful as muscarinic receptor antagonists
05/17/2012US20120122849 Pkm2 modulators for use in the treatment of cancer
05/17/2012US20120122848 (+)-3-hydroxymorphinan derivatives as neuroprotectants
05/17/2012US20120122847 Aurora kinase modulators and method of use
05/17/2012US20120122839 Novel pyrrolidin-2-ones
05/17/2012US20120122838 Heterocyclic compounds and uses thereof
05/17/2012US20120122837 Inhibitors of fatty acid binding protein
05/17/2012US20120122773 N-substituted-cyclic amino derivative
05/17/2012US20120122136 Self-immolative probes for enzyme activity detection
05/17/2012US20120121934 Chromene compound
05/17/2012US20120121727 Substituted dihydropyrazolones for treating cardiovascular and hematological diseases
05/17/2012US20120121502 Pyrimidine hydroxy amide compounds as protein deacetylase inhibitors and methods of use thereof
05/16/2012EP2451808A1 Pyridazine compounds for controlling invertebrate pests
05/16/2012EP2451804A1 Pyridazine compounds for controlling invertebrate pests
05/16/2012EP2451803A2 Method for preparing 5-chloro-n-({(5s)-2-oxo-3-[4-(5,6-dihydro-4h-[1,2,4]triazin-1-yl)phenyl]-1,3-oxazolidin-5-yl}methyl)thiophen-2-carboxamide derivative and intermediate used therein
05/16/2012EP2451800A1 1-(6 members azo-heterocyclic)-pyrrolin-2-one compounds as inhibitors of hepatitis c ns5b polymerase, the pharmaceutical composition thereof and their therapeutic use
05/16/2012EP2451790A1 Histone deacetylase inhibitors
05/16/2012EP2451782A1 Dual-acting pyrazole antihypertensive agents
05/16/2012EP2451285A1 Platelet-activating factor receptor antagonists
05/16/2012EP2307383B1 Aminotetrahydroindazoloacetic acids
05/16/2012EP2183247B1 New crystalline forms of 2 -hydroxy- 3- [5- (morpholin- 4- ylmethyl) pyridin-2-yl]1h- indole- 5 -carbonitrile citrate
05/16/2012EP2144902B1 [6,6]and [6,7]-bicyclic gpr119 g protein-coupled receptor agonists
05/16/2012EP2044028B1 Cyanoisoquinoline compounds that stabilize hypoxia inducible factor (hif)
05/16/2012EP1864665B1 Immunosuppressive agent comprising a heterocyclic compound as active ingredient
05/16/2012EP1851199B1 Substituted bis aryl and heteroaryl compounds as selective 5ht2a antagonists
05/16/2012CN102459253A Oxazole substituted indazoles as pi3-kinase inhibitors
05/16/2012CN102459252A 用于治疗糖原合酶激酶3相关疾病诸如阿尔茨海默病的咪唑取代的嘧啶 For the treatment of glycogen synthase kinase 3-related diseases such as Alzheimer's disease pyrimidine substituted imidazole
05/16/2012CN102459251A 作为白三烯a4水解酶的调节剂的具有两个稠合双环杂芳基部分的化合物 Compound bicyclic heteroaryl moiety having two fused leukotriene a4 hydrolase as modulators of
05/16/2012CN102459250A 丙型肝炎病毒抑制剂 Hepatitis C virus inhibitors
05/16/2012CN102459249A 作为PI3K/mTOR抑制剂的苯并氧氮杂环庚三烯以及它们使用与制造方法 As the PI3K / mTOR inhibitor benzoxazepine cycloheptatriene and their use and manufacturing method
05/16/2012CN102459248A 作为PI3K/mTOR抑制剂的苯并氧杂环庚三烯以及它们使用与制造方法 As the PI3K / mTOR inhibitor benzoxepin-triene and their method of use and manufacture
05/16/2012CN102459247A 作为醛固酮合酶抑制剂的苯并噁唑酮衍生物 As aldosterone synthase inhibitors benzoxazole derivatives
05/16/2012CN102459246A 作为治疗剂的异噁唑-3(2h)-酮类似物 As therapeutic agents isoxazole -3 (2h) - one analogues
05/16/2012CN102459236A 激酶活性的嘧啶抑制剂 Pyrimidine inhibitors of kinase activity
05/16/2012CN102459232A 7-aza-spiro[3.5]nonane-7-carboxylate derivatives, preparation thereof, and therapeutic use thereof
05/16/2012CN102459229A 用作食欲肽拮抗剂的3-氮杂二环[4.1.0]庚烷 Orexin antagonists used azabicyclo [4.1.0] heptane
05/16/2012CN102459228A Azetidinyl diamides as monoacylglycerol lipase inhibitors
05/16/2012CN102459227A Ccr2的4-氮杂环丁烷基-1-苯基-环己烷拮抗剂 Ccr2 4-azetidinyl-1-phenyl - cyclohexane antagonist
05/16/2012CN102459226A Ccr2的4-氮杂环丁烷基-1-杂原子连接的-环己烷拮抗剂 Ccr2 4-azetidinyl -1- heteroatom attached - cyclohexane antagonist
05/16/2012CN102459225A Ccr2的4-氮杂环丁烷基-1-杂芳基-环己烷拮抗剂 Ccr2 4-azetidinyl -1- heteroaryl - cyclohexane antagonist
05/16/2012CN102459223A 5-pyridin-3-yl-1,3-dihydro-indol-2-on derivatives and their use as modulators of aldosterone synthase and/or cyp11b1
05/16/2012CN102459216A Inhibitors of the renal outer medullary potassium channel
05/16/2012CN102459207A 环戊二烯并[c]吡咯-2-甲酸酯衍生物、其制备及其治疗用途 Cyclopenta [c] pyrrole-2-carboxylic acid ester derivatives, their preparation and their therapeutic use
05/16/2012CN102459205A Herbicidal benzoxazinones
05/16/2012CN102459189A 5-元杂环化合物环戊二烯并[c]吡咯基烷基氨基甲酸酯衍生物、其制备、及其治疗用途 5-membered heterocyclic compound cyclopenta [c] pyrrolyl group carbamate derivatives, their preparation, and their therapeutic use
05/16/2012CN102459185A 新型甲状腺激素β受体激动剂 Novel thyroid hormone receptor β agonists
05/16/2012CN102459183A Inhibitors of human immunodeficiency virus replication
05/16/2012CN102459167A Azetidinyl diamides as monoacylglycerol lipase inhibitors
05/16/2012CN102459165A 抗病毒化合物 Antiviral compounds
05/16/2012CN102458402A Nicotinamide compounds useful as kinase modulators
05/16/2012CN102453028A Antifungal agent 2-[(2,3-dihydro-4H-benzo-[b]thiapyran-4-ylidene) hydrazono]-4-oxotetrahydro thiazole (oxazole)-5-acetic acid derivative
05/15/2012US8178694 Heterocyclylaminoalkyl substituted benzimidazoles
05/15/2012US8178693 N3 alkylated benzimidazole derivatives as MEK inhibitors
05/15/2012US8178683 Antimicrobial ortho-fluorophenyl oxazolidinones for treatment of bacterial infections
05/15/2012US8178671 Methods of treating or preventing autoimmune diseases with 2, 4-pyrimidinediamine compounds
05/15/2012US8178668 2-aminopyridine kinase inhibitors
05/15/2012US8178667 Benzyl-substituted quinolone M1 receptor positive allosteric modulators
05/15/2012US8178666 2-aminobenzoxazole process
05/15/2012US8178665 Process for the production of ezetimibe and intermediates used in this process
05/15/2012US8178579 Histone deacetylase inhibitors; anticancer agents; antiprotozoa agents
05/15/2012US8178562 Pyridine derivatives
05/15/2012US8178560 Therapeutic agents useful for treating pain
05/15/2012US8178559 Organic compounds
05/15/2012US8178557 Compounds and methods of use
05/15/2012US8178549 Azabicyclo [3. 1. O] hexyl derivatives as modulators of dopamine D3 receptors
05/15/2012US8178532 c-Met modulators and method of use
05/15/2012US8178531 Antiviral agents
05/15/2012US8178529 Imidazole substituted pyrimidines
05/15/2012US8178528 Histamine H3 receptor agents, preparation and therapeutic uses
05/15/2012US8178527 Tetra-substituted NDGA derivatives via ether bonds and carbamate bonds and their synthesis and pharmaceutical use
05/15/2012US8178526 Compounds and compositions as ITPKb inhibitors
05/15/2012US8178525 FXA inhibitors with cyclic amidoxime or cyclic amidrazone as P4 subunit, processes for their preparations, and pharmaceutical compositions and derivatives thereof
05/15/2012CA2670703C Azacycloalkane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase
05/15/2012CA2546781C Cycloalkyl derivatives of 3-hydroxy-4-pyridinones
05/15/2012CA2463569C Activator for peroxisome proliferator-activated receptor .delta.
05/15/2012CA2430978C Vla-4 inhibitors
05/10/2012WO2012061698A2 Compounds useful as modulators of trpm8
05/10/2012WO2012061602A1 Isoindolinone kinase inhibitors
05/10/2012WO2012061459A1 Heterocyclic compounds as s1p1 agonists for the treatment of autoimmune and vascular diseases
05/10/2012WO2012061337A1 Fgfr2 modulators
05/10/2012WO2012060738A1 CLATHRATE COMPLEXES OF β-CYCLODEXTRIN WITH 1-{[6-BROMO-1-METHYL-5-METHOXY-2-PHENYLTHIOMETHYL-1-H-INDOLE-3-YL]CARBONYL}-4-BENZYLPIPERAZINE HAVING ANTIVIRAL ACTIVITY, THE PRODUCTION AND USE THEREOF
1 ... 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 ... 647